Trabikibart, CAS 2643974-98-3

Product Description: Trabikibart (CSL311), a βc-specific, fully human monoclonal antibody, binds to a unique epitope that is specific to the cytokine-binding site of the human βc receptor. Trabikibart has picomolar binding affinity for the human βc receptor. Trabikibart is a potent inhibitor of the combined effects of IL-3, GM-CSF and IL-5 on the survival of eosinophils. Trabikibart has the potential for chronic inflammatory diseases research[1].

Applications: COVID-19-immunoregulation

Formula: N/A

References: [1]Con Panousis, et al. CSL311, a novel, potent, therapeutic monoclonal antibody for the treatment of diseases mediated by the common β chain of the IL-3, GM-CSF and IL-5 receptors. MAbs. 2016;8(3):436-53.

CAS Number: 2643974-98-3

Molecular Weight: N/A

Research Area: Inflammation/Immunology

Solubility: 10 mM in DMSO

Target: Others

• Artikelnummer: MEXHY-P990094-0
• Hersteller: MedChemExpress
• Hersteller Artikelnummer: HY-P990094-0
• Green Labware: Nein
• Verpackungseinheit: Get quote
• Mengeneinheit: STK